Author

John Abernathy

University of Tennessee Health Science Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alexandra Cullom· 1 shared Bernd MeibohmiD· 1 shared Bhargavi ThalluriiD· 1 shared Damilola OluwalanaiD· 1 shared Deanna N. ParkeiD· 1 shared Dejian MaiD· 1 shared Duane D. MilleriD· 1 shared Hao Chen· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexandra Cullom

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer

Damilola Oluwalana, Kelli L. Adeleye, Raisa I. Krutilina, Hao Chen, Hilaire C. Playa, Shanshan Deng, Deanna N. Parke, John Abernathy, Leona Middleton, Alexandra Cullom, Bhargavi Thalluri, Dejian Ma, Bernd Meibohm, Duane D. Miller, Tiffany Nicole Seagroves, Wěi Li

This study evaluates the biological activity of 60c, a next-generation colchicine-binding site inhibitor, showing improved potency and anti-metastatic effects in triple-negative breast cancer models.

Cancer Letters · May 23, 2024Peer-reviewedCancer Biology